At first glance, it looked interesting because it behaved somewhat like GLP-1, a hormone involved in blood sugar regulation
Pull up the right dose, purge air, inject subcutaneous, and hold for 5 seconds
#Pharma #Obesity #WeightLoss #DrugDevelopment #ClinicalTrials #Roche #NovoNordisk #MetabolicHealth #HealthcareInnovation Source: Roche CT-388 mid-stage obesity trial Novo Nordisk zenagamtide mid-stage diabetes study To view or add a comment, sign in Treatment-Resistant Hypertension (TRH) Market is Projected to Boom by 2036 Owing to the Launch of Novel Therapies | DelveInsight: The market dynamics for Treatment-Resistant Hypertension (TRH) is witnessing steady growth driven by the increasing prevalence of hypertension, growing burden of obesity, diabetes, and chronic kidney disease, improving diagnosis rates, and the introduction of novel antihypertensive therapies
Will I gain weight back if I stop
Fact: Balance is key
This pathway primes GH vesicles for release and upregulates GH gene transcription